- 2016
-
Press releases - 05.08.2016
One hour of physical activity per day may attenuate the increased risk of death associated with sitting time
A meta-analysis of data from over one million people, published on July 27th in a new Series of The Lancet ahead of the 2016 Summer Olympic Games, emphasize the importance of physical activity to attenuate the harmful effect of sitting time.
-
What's on? - 05.08.2016
One hour of physical activity per day may attenuate the increased risk of death associated with sitting time
A meta-analysis of data from over one million people, published on July 27th in a new Lancet Series ahead of the 2016 Summer Olympic Games, emphasize the importance of physical activity to attenuate the harmful effect of sitting time. The researchers classified individuals into four groups according to how active they were, less than 5 mins a day, […]
-
Press releases - 29.07.2016
A virtual brain helps decrypt epilepsy
Researchers at CNRS, INSERM, Aix-Marseille University and AP-HM have just created a virtual brain that can reconstitute the brain of a person affected by epilepsy for the first time. From this work we understand better how the disease works and can also better prepare for surgery. These results are published in Neuroimage, on July 28, 2016.
-
Press releases - 27.07.2016
Inserm, France’s rising research star according to Nature
The French National Institute of Health and Medical Research (Inserm) is the only research institution in France listed in the World Top 100 institutions with the most progress in the last 3 years. This is indicated by the Nature Index 2016 Rising Stars, which highlights the big contribution of Inserm researchers to publications in the best 68 journals selected by Nature. This ranking identifies the most brilliant institutions to watch in 2016 and in the coming years.
-
News in brief - 26.07.2016
Schizophrenics: type of birth and particularities of the disease
According to a few studies, when their brain suffers from a lack of oxygen, babies born by caesarean section are more likely to develop some mental disorders including schizophrenia. Researchers from Inserm compared two populations of patients with schizophrenia – delivered vaginally or by caesarean section – in order to determine the particular characteristics associated […]
-
What's on? - 22.07.2016
Thursday 28 July 2016: World Hepatitis Day
Hepatitis is an inflammation of the liver, most often caused by a virus, in which case it is referred to as viral hepatitis. Toxic substances, such as alcohol or certain drugs, may also be responsible for cases of toxic hepatitis. Of the six known types of hepatitis virus (A, B, C, D, E and […]
-
Press releases - 22.07.2016
Omega-3 fatty acids and stress management: growing links
The relationship between omega-3 fatty acid intake and adaptation to stress or anxiety is becoming clearer. Back in 2011, a team of researchers from INRA and Inserm showed that reducing the intake of omega-3 fatty acids in mice increased their stress. This phenomenon may be linked to impairment of the brain’s ability to produce endogenous cannabinoids, the “endocannabinoids,” brain lipids that control synaptic memory. To better understand the endocannabinoid-dependent links between anxiety and synaptic plasticity, the research team continued its experiments by testing different models of behavioural stress on the rodents. These studies are the subject of an article published in the journal Cell Reports on 21 July.
-
Press releases - 21.07.2016
Long term correction of hyperbilirubinemia in animal models of Crigler-Najjar syndrome after AAV vector-mediated liver gene transfer
Dr. Federico MINGOZZI, Team Leader of the Immunology and Liver Gene Transfer unit at Généthon, (Inserm U951/UPMC), France, has demonstrated the long-term efficacy of an optimized AAV-UGT1A1 vector for the correction of Crigler-Najjar syndrome (CN) in two different animal models of the disease. This work, published in July 20, 2016 in Molecular Therapy Methods and Clinical Development was supported by the AFM-Telethon.
-
Press releases - 20.07.2016
An antibody-based drug for multiple sclerosis
Inserm Unit U919, directed by Prof. Denis Vivien (“Serine Proteases and Physiopathology of the Neurovascular Unit”) has developed an antibody with potential therapeutic effects against multiple sclerosis. The study, directed by Fabian Docagne and published in Brain, paves the way for a new strategy to control the disease.
-
Press releases - 19.07.2016
Attacks and risks of post-traumatic stress
In a traumatic event, such as the attacks on Paris on 13 November 2015, and on Nice on 14 July 2016, the risk for victims and witnesses of developing post-traumatic stress disorder (PTSD) is high.